Intuitive Surgical Q4 EPS Tops Estimates; Foundations Sells 93.3% Stake
Foundations Investment Advisors sold 37,895 Intuitive Surgical shares in Q3, cutting its stake by 93.3% to 2,715 shares worth $1.214M. Intuitive Surgical reported Q4 earnings of $2.53 per share versus $2.27 expected and revenue of $2.87B versus $2.72B.
1. Institutional Investor Activity
Foundations Investment Advisors LLC reduced its stake in Intuitive Surgical by 93.3% during the third quarter, disposing of 37,895 shares and retaining just 2,715 shares valued at approximately $1.214 million according to its latest SEC filing. Other institutional moves included Strategic Advisors LLC increasing its position by 63.3%, adding 4,031 shares to reach 10,397 shares (worth about $4.65 million), AE Wealth Management LLC raising its holding by 18.9% to 11,556 shares (roughly $5.17 million), LRI Investments LLC lifting its stake by 24.0% to 1,997 shares (around $893,000), Birchbrook Inc. growing its position by 5.1% to 1,533 shares (near $686,000) and Activest Wealth Management adding 20 shares for a 21.7% gain to 112 shares (about $50,000). Collective ownership by institutional investors and hedge funds now stands at 83.64%.
2. Q4 Earnings and Financial Metrics
In its most recent quarter, Intuitive Surgical reported earnings per share of $2.53, surpassing consensus estimates by $0.26. Revenue reached $2.87 billion, outpacing analyst expectations by $150 million and marking an 18.8% year-over-year increase. The company delivered a return on equity of 15.06% and maintained a net margin of 28.38%. On a trailing-four-quarter basis, revenue growth was driven by higher procedure volumes across core robotic platforms, and management projects full-year earnings per share of 6.43 based on current analyst consensus.
3. Analyst Ratings and Outlook
Several research firms updated their views on Intuitive Surgical in recent months. HSBC Global Research upgraded the stock to a strong-buy, while Citigroup maintained a neutral stance despite lowering its targets. Daiwa Capital Markets and Leerink Partners both reiterated outperform ratings following upward revisions to their forecasts, and Evercore ISI moved to an in-line rating after adjusting its outlook downward. Overall, analyst sentiment remains positive: out of 25 covering firms, two assign a strong-buy rating, fourteen a buy, eight a hold and one a sell, resulting in an average consensus rating of Moderate Buy.